Heidegger, I. (Contributor), Fotakis, G. (Contributor), Offermann, A. (Contributor), Keller, M. A. (Contributor), Wolf, D. (Contributor), Schäfer, G. (Contributor), Haybaeck, J. (Contributor), Daum, S. (Contributor), Krogsdam, A. (Contributor), Klocker, H. (Contributor), Pircher, A. (Contributor), Noureen, A. (Contributor), Plattner, C. (Contributor), Timmer-Bosscha, H. (Contributor), Goveia, J. (Contributor), Salcher, S. (Contributor), Walenkamp, A. (Contributor), Beatovic, A. (Contributor), Sopper, S. (Contributor), Trajanoski, Z. (Contributor), Moisse, M. (Contributor), Thaler, S. (Contributor), Perner, S. (Contributor) (
19-Jun-2022). Additional file 10 of Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer. figshare Academic Research System.
10.6084/m9.figshare.20098784.v1